Colorado Pharmacies Concerned Over PDAB UPL Reimbursements

By Luke Zarzecki / April 17, 2024 at 11:20 AM
Colorado pharmacies are concerned they may not receive adequate reimbursement after the state’s prescription drug affordability board (PDAB) determines an upper payment limit (UPL) for drugs it deems unaffordable, and a pharmacy group says it has unanswered questions about the process. Eyes are on Colorado’s PDAB as it is the first state in the nation to consider setting a UPL on a drug. The board is currently considering whether to set an upper payment limit on Amgen’s drug Enbrel, used...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.